- Repligen Corporation (RGEN, Financial) to announce Q1 2025 financial results on April 29, 2025.
- Conference call scheduled at 8:30 a.m. ET will discuss quarterly results and business updates.
- Webcast and replay options available on the company's Investor Relations website.
Repligen Corporation (NASDAQ:RGEN) has announced its plans to report the financial results for the first quarter of 2025 on Tuesday, April 29, 2025. The results will cover the three-month period ending March 31, 2025. The company will release its earnings press release before the market opens.
A conference call is scheduled at 8:30 a.m. ET on the same day to discuss the quarterly financial performance and business updates. Investors can join the call by dialing the toll-free number (844) 274-3999 for U.S. participants or (412) 317-5607 for international callers. The webcast will be accessible through the Investor Relations section of Repligen's website.
For those unable to join live, a replay of the conference call will be available. Interested parties can dial (877) 344-7529 in the U.S., (855) 669-9658 in Canada, or (412) 317-0088 internationally, using the passcode 6386085 to access the replay.
Repligen, headquartered in Waltham, Massachusetts, is recognized for developing and commercializing innovative bioprocessing technologies. The company serves biopharmaceutical drug developers and contract development and manufacturing organizations worldwide.
